TScan Therapeutics Files 2023 10-K
Ticker: TCRX · Form: 10-K · Filed: 2024-03-06T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, biotech, annual-report
TL;DR
TScan Therapeutics filed its 2023 10-K. All systems go for reporting.
AI Summary
TScan Therapeutics, Inc. filed its 2023 10-K on March 6, 2024, reporting on its fiscal year ending December 31, 2023. The company, focused on biological products, operates from Waltham, MA. Key events and financial details from the filing are not explicitly detailed in this header information, but it establishes the company's reporting status and fiscal year end.
Why It Matters
This filing provides a comprehensive overview of TScan Therapeutics' financial health, operational performance, and strategic direction for the fiscal year 2023, crucial for investors and stakeholders.
Risk Assessment
Risk Level: medium — As a biotechnology company, TScan Therapeutics is subject to inherent risks related to drug development, clinical trials, regulatory approvals, and market competition.
Key Numbers
- 2023-12-31 — Fiscal Year End (The end date of the reporting period for the 10-K)
- 20240306 — Filing Date (The date the 10-K was officially filed with the SEC)
Key Players & Entities
- TScan Therapeutics, Inc. (company) — Filer of the 10-K report
- 880 WINTER STREET (location) — Business and mailing address
- WALTHAM (location) — City of business and mailing address
- MA (location) — State of business and mailing address
- 02451 (location) — ZIP code of business and mailing address
- Novartis (company) — Mentioned in relation to research funding
FAQ
What is TScan Therapeutics' primary business focus?
TScan Therapeutics, Inc. is primarily involved in the development of biological products, specifically in the area of biological products (no diagnostic substances) as indicated by its SIC code [2836].
When did TScan Therapeutics file its 10-K report?
TScan Therapeutics filed its 10-K report on March 6, 2024.
What is the principal business address of TScan Therapeutics?
The principal business address for TScan Therapeutics is 880 Winter Street, Waltham, MA 02451.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2023.
Is there any mention of collaborations or licensing revenue in the provided header?
Yes, the header includes a URL pointing to 'CollaborationAndLicenseRevenue' for the fiscal year 2023, suggesting this is a relevant area for the company.
From the Filing
0000950170-24-026875.txt : 20240306 0000950170-24-026875.hdr.sgml : 20240306 20240306073034 ACCESSION NUMBER: 0000950170-24-026875 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 97 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240306 DATE AS OF CHANGE: 20240306 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 24724376 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 10-K 1 tcrx-20231231.htm 10-K 10-K 0001783328 false FY http://www.tscan.com/20231231#CollaborationAndLicenseRevenue http://www.tscan.com/20231231#CollaborationAndLicenseRevenue http://fasb.org/us-gaap/2023#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember March 31, 2020 0001783328 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0001783328 srt:MaximumMember 2023-11-08 2023-11-08 0001783328 tcrx:ResearchFundingMember tcrx:NovartisMember 2020-03-01 2020-03-31 0001783328 2023-01-01 2023-12-31 0001783328 tcrx:VotingCommonStockMember us-gaap:CommonStockMember 2021-12-31 0001783328 tcrx:OfficeAndComputerEquipmentMember srt:MinimumMember 2023-12-31 0001783328 2023-11-08 2023-11-08 0001783328 tcrx:TwoThousandAndTwentyOneEquityIncentivePlanMember 2021-07-15 2021-07-15 0001783328 us-gaap:NonvotingCommonStockMember 2022-12-31 0001783328 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001783328 us-gaap:CommonStockMember us-gaap:NonvotingCommonStockMember 2023-12-31 0001783328 us-gaap:ConvertibleDebtSecuritiesMember 2022-01-01 2022-12-31 0001783328 2023-11-08 0001783328 tcrx:FollowOnOfferingMember tcrx:VotingCommonStockMember 2023-06-01 2023-06-01 0001783328 us-gaap:FairValueInputsLevel3Member 2023-12-31 0001783328 tcrx:K2HealthVenturesMember 2023-01-01 2023-12-31 0001783328 tcrx:TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember us-gaap:EmployeeStockOptionMember 2023-12-31 0001783328 us-gaap:LetterOfCreditMember 2023-12-31 0001783328 tcrx:VotingCommonStockMember us-gaap:CommonStockMember 2022-12-31 0001783328 tcrx:VotingCommonStockMember tcrx:WedbushSecuritiesIncMember tcrx:SalesAgreementMember 2023-05-16 0001783328 us-gaap:ConstructionInProgressMember 2023-12-31 0001783328 tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001783328 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001783328 tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember 2021-07-15 0001783328 2022-12-31 0001783328 tcrx:TwoThousandEighteenAndTwoThousandTwentyOneEquityIncentivePlanMember us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001783328 2022-09-09 2022-09-09 0001783328 tcrx:TwoThousandAndTwentyOneEquityIncentivePlanMember 2021-07-14 0001783328 tcrx:NovartisMember 2020-03-31 2020-03-31 0001783328 tcrx:NovartisMember 2022-01-01 2022-12-31 0001783328 tcrx:LaboratoryEquipmentMember 2022-12-31 0001783328 tcrx:NovartisAgreementMember srt:MinimumMember 2020-03-31 0001783328 tcrx:AmgenIncMember tcrx:AmgenAgreementMember 2023-05-08 2023-05-08 0001783328 srt:MinimumMember 2023-11-08 2023-11-08 0001783328 us-gaap:RetainedEarningsMember 2021-12-31 0001783328 us-gaap:RetainedEarningsMember 2022-12-31 0001783328 tcrx:K2HealthVenturesMember us-gaap:PrimeRateMember 2022-09-09 2022-09-09 0001783328 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001783328 tcrx:TwoThousandAndTwentyOneEmployeeStockPurchasePlanMember 2021-07-14 0001783328 tcrx:AmgenIncMember tcrx:AmgenAgreementMember 2023-12-31 0001783328 stpr:MA 2023-01-01 2023-12-31 0001783328 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2023-12-31 0001783328 us-gaap:GeneralAndAdministra